MASH: Silent Epidemic

Here’s a summary of the WorldHealth.net article “Liver Health and MASH: What You Need to Know About the Silent Epidemic”: 🩺 What is MASH? MASH (Metabolic Dysfunction-Associated Steatohepatitis), formerly NASH, is an advanced form of fatty liver disease characterized...

Long Wait Times (except with LiverRight)

Wait times to see a provider in America are long … and even more so in Liver Disease (Hepatology). Give this June-2025 article Wait Times to See Physicians Continue to Climb a read (summarized below).LiverRight gets adult patients for diagnosis or care in...

Steatotic Liver Disease: Mortality Risks

From JAMA Internal Medicine, June 16, 2025: Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease. Objective:To compare the risk of adverse liver outcomes, major cardiovascular events, and all-cause mortality among people with...

State of Hepatitis in the USA

🏆 States on‑track to eliminate HCV by 2030 A 2020–17 model projected only three states—Connecticut, South Carolina, and Washington—are on pace to meet all WHO HCV elimination targets (diagnosis, treatment, incidence, mortality) by 2030 💊 Medicaid innovations &...

State of HCV in USA

This superb site will tell you your state’s Hepatitis C grade. https://stateofhepc.org/From their website– “Hepatitis C: State of Medicaid Access is the culmination of work by the Center for Health Law and Policy Innovation of Harvard Law School...